Free Trial

Praxis Precision Medicines (PRAX) Competitors

Praxis Precision Medicines logo
$53.85 -1.09 (-1.98%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$53.86 +0.00 (+0.01%)
As of 07/18/2025 07:26 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PRAX vs. KRYS, AKRO, RNA, PTCT, ACLX, MRUS, ZLAB, SRRK, ACAD, and VKTX

Should you be buying Praxis Precision Medicines stock or one of its competitors? The main competitors of Praxis Precision Medicines include Krystal Biotech (KRYS), Akero Therapeutics (AKRO), Avidity Biosciences (RNA), PTC Therapeutics (PTCT), Arcellx (ACLX), Merus (MRUS), Zai Lab (ZLAB), Scholar Rock (SRRK), ACADIA Pharmaceuticals (ACAD), and Viking Therapeutics (VKTX). These companies are all part of the "pharmaceutical products" industry.

Praxis Precision Medicines vs. Its Competitors

Krystal Biotech (NASDAQ:KRYS) and Praxis Precision Medicines (NASDAQ:PRAX) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, dividends, valuation, media sentiment, earnings, risk, analyst recommendations and profitability.

86.3% of Krystal Biotech shares are owned by institutional investors. Comparatively, 67.8% of Praxis Precision Medicines shares are owned by institutional investors. 13.7% of Krystal Biotech shares are owned by company insiders. Comparatively, 2.7% of Praxis Precision Medicines shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Krystal Biotech has higher revenue and earnings than Praxis Precision Medicines. Praxis Precision Medicines is trading at a lower price-to-earnings ratio than Krystal Biotech, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Krystal Biotech$290.52M14.67$89.16M$4.1635.45
Praxis Precision Medicines$8.12M135.05-$182.82M-$10.72-5.02

Krystal Biotech currently has a consensus target price of $213.75, suggesting a potential upside of 44.93%. Praxis Precision Medicines has a consensus target price of $94.11, suggesting a potential upside of 74.77%. Given Praxis Precision Medicines' higher probable upside, analysts plainly believe Praxis Precision Medicines is more favorable than Krystal Biotech.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Krystal Biotech
0 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
3.00
Praxis Precision Medicines
1 Sell rating(s)
0 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.78

Krystal Biotech has a net margin of 37.17% compared to Praxis Precision Medicines' net margin of -2,137.48%. Krystal Biotech's return on equity of 14.64% beat Praxis Precision Medicines' return on equity.

Company Net Margins Return on Equity Return on Assets
Krystal Biotech37.17% 14.64% 13.28%
Praxis Precision Medicines -2,137.48%-50.42%-46.74%

Krystal Biotech has a beta of 0.67, meaning that its stock price is 33% less volatile than the S&P 500. Comparatively, Praxis Precision Medicines has a beta of 2.6, meaning that its stock price is 160% more volatile than the S&P 500.

In the previous week, Krystal Biotech had 18 more articles in the media than Praxis Precision Medicines. MarketBeat recorded 28 mentions for Krystal Biotech and 10 mentions for Praxis Precision Medicines. Praxis Precision Medicines' average media sentiment score of 0.53 beat Krystal Biotech's score of -0.14 indicating that Praxis Precision Medicines is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Krystal Biotech
11 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Praxis Precision Medicines
1 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Krystal Biotech beats Praxis Precision Medicines on 12 of the 17 factors compared between the two stocks.

Get Praxis Precision Medicines News Delivered to You Automatically

Sign up to receive the latest news and ratings for PRAX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PRAX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PRAX vs. The Competition

MetricPraxis Precision MedicinesMED IndustryMedical SectorNASDAQ Exchange
Market Cap$1.10B$2.93B$5.53B$9.41B
Dividend YieldN/A2.48%3.76%4.04%
P/E Ratio-5.0219.8828.2619.78
Price / Sales135.05293.75412.9994.60
Price / CashN/A41.8435.8558.18
Price / Book2.257.678.115.65
Net Income-$182.82M-$55.28M$3.25B$257.97M
7 Day Performance6.55%4.87%1.63%3.74%
1 Month Performance27.18%13.14%7.62%11.95%
1 Year Performance-2.02%3.51%32.74%19.22%

Praxis Precision Medicines Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PRAX
Praxis Precision Medicines
2.4747 of 5 stars
$53.85
-2.0%
$94.11
+74.8%
-2.0%$1.10B$8.12M-5.02110News Coverage
Analyst Forecast
Analyst Revision
KRYS
Krystal Biotech
4.5323 of 5 stars
$150.41
+1.5%
$213.75
+42.1%
-27.6%$4.35B$290.52M36.16210News Coverage
Insider Trade
Analyst Revision
AKRO
Akero Therapeutics
3.663 of 5 stars
$52.73
+2.2%
$82.50
+56.5%
+94.6%$4.20BN/A-27.0430Insider Trade
RNA
Avidity Biosciences
2.4033 of 5 stars
$33.57
+6.7%
$66.35
+97.7%
-25.2%$4.05B$8.93M-11.19190High Trading Volume
PTCT
PTC Therapeutics
4.3322 of 5 stars
$49.46
+1.9%
$65.00
+31.4%
+46.0%$3.92B$806.78M7.601,410News Coverage
Insider Trade
Analyst Revision
ACLX
Arcellx
2.5441 of 5 stars
$69.92
+1.4%
$111.23
+59.1%
+8.0%$3.85B$76.81M-23.3880Positive News
MRUS
Merus
2.1551 of 5 stars
$55.62
+2.1%
$84.64
+52.2%
+14.4%$3.85B$36.13M-13.6337News Coverage
Analyst Downgrade
Insider Trade
ZLAB
Zai Lab
3.3581 of 5 stars
$34.28
+4.7%
$54.28
+58.3%
+79.9%$3.81B$398.99M-13.771,869Positive News
Gap Up
SRRK
Scholar Rock
3.2472 of 5 stars
$38.59
+3.1%
$42.67
+10.6%
+367.5%$3.66B$33.19M-15.25140Analyst Forecast
Insider Trade
Analyst Revision
ACAD
ACADIA Pharmaceuticals
3.9759 of 5 stars
$21.89
+4.3%
$27.88
+27.3%
+27.1%$3.66B$957.80M15.98510
VKTX
Viking Therapeutics
4.6049 of 5 stars
$31.63
+1.7%
$87.15
+175.5%
-37.1%$3.55BN/A-27.5020Positive News
Upcoming Earnings

Related Companies and Tools


This page (NASDAQ:PRAX) was last updated on 7/20/2025 by MarketBeat.com Staff
From Our Partners